A Phase III Trial For Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms|Cancer of the Breast
Interventions: DRUG: gemcitabine|DRUG: docetaxel|DRUG: capecitabine
Sponsor: Eli Lilly and Company